Reports Q2 revenue $52.5M, consensus $42.42M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMDX:
- TransMedics Reports Second Quarter 2023 Financial Results
- Bridge to Life Divests Certain Assets to TransMedics
- TransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to Life
- TransMedics acquires assets from Bridge to Life
- TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation